FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385871738> ?p ?o ?g. }

• W4385871738 endingPage "705" @default.
• W4385871738 startingPage "693" @default.
• W4385871738 abstract "BackgroundBipolar depression constitutes a major public health problem due to its substantial burden of disease. Although pharmacological interventions are available, guidelines required updated evidence synthesis to improve their current recommendations. In order to inform evidence-based prescribing, we investigated the comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression.MethodsWe conducted a systematic review and network meta-analysis. We searched for randomised controlled trials comparing pharmacological interventions with each other or placebo in adults with acute bipolar depression (type I, type II, or not otherwise specified), excluding those with substance misuse, unipolar depression, or schizophrenia, in MEDLINE, Embase, PsycINFO, Google Scholar, Cochrane Library, Web of Knowledge, CINAHL, and LILACS from database inception up to April 13, 2023. Criteria for eligibility were a duration of 2–16 weeks with masked outcome assessments, and we included combination, add-on design, and monotherapy studies. The co-primary outcomes were depressive symptoms, examined with standardised mean differences (SMDs), and manic switch, examined with odds ratios (ORs). We also investigated dropouts due to any reason, inefficacy, adverse events, and important side-effects as secondary outcomes. The confidence in the evidence was evaluated using Confidence-In-Network-Meta-Analysis (CINeMA). The study was registered with PROSPERO, CRD42020171726.ResultsWe analysed data from 101 randomised controlled trials covering 20 081 participants, 8063 men (41·7%) and 11 263 women (58·3%; sex not available in four studies), mean age 41·0 years (range of means 28·7–53·6 years), and 68 medications and placebo. Ethnicity data were not available. With moderate confidence in the evidence, olanzapine plus fluoxetine, quetiapine, olanzapine, lurasidone, lumateperone, cariprazine, and lamotrigine were more efficacious than placebo in reducing depressive symptoms, with SMDs ranging from 0·41 (95% CI 0·19–0·64) for olanzapine plus fluoxetine to 0·16 (0·03–0·29) for lamotrigine. Several other drugs might also be efficacious, but the confidence in the evidence was very low to low. Antidepressants as a class seem to be efficacious, but had a higher risk for manic switch compared to antipsychotics. Medications differed in their side-effect profiles.InterpretationThis is, to our knowledge, the largest network meta-analysis of pharmacotherapy for bipolar depression to date. Olanzapine plus fluoxetine, quetiapine, olanzapine, lurasidone, lumateperone, cariprazine, and lamotrigine were found to be more efficacious than placebo in adults with acute bipolar depression, with good confidence in the evidence, and to differ in their side-effect profiles. These findings can inform evidence-based care and the development of treatment guidelines internationally.FundingNone." @default.
• W4385871738 created "2023-08-17" @default.
• W4385871738 creator A5002251483 @default.
• W4385871738 creator A5011934579 @default.
• W4385871738 creator A5061926369 @default.
• W4385871738 creator A5082687875 @default.
• W4385871738 creator A5086167151 @default.
• W4385871738 date "2023-09-01" @default.
• W4385871738 modified "2023-10-18" @default.
• W4385871738 title "Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis" @default.
• W4385871738 cites W1525161423 @default.
• W4385871738 cites W1617328014 @default.
• W4385871738 cites W1967878789 @default.
• W4385871738 cites W1977083089 @default.
• W4385871738 cites W1982924223 @default.
• W4385871738 cites W1999204807 @default.
• W4385871738 cites W2075046475 @default.
• W4385871738 cites W2091808438 @default.
• W4385871738 cites W2107950329 @default.
• W4385871738 cites W2111999709 @default.
• W4385871738 cites W2125390848 @default.
• W4385871738 cites W2131701504 @default.
• W4385871738 cites W2143162969 @default.
• W4385871738 cites W2157823046 @default.
• W4385871738 cites W2168718800 @default.
• W4385871738 cites W2237437504 @default.
• W4385871738 cites W2324187437 @default.
• W4385871738 cites W2756281492 @default.
• W4385871738 cites W2790303747 @default.
• W4385871738 cites W2792027821 @default.
• W4385871738 cites W2926608910 @default.
• W4385871738 cites W2957311488 @default.
• W4385871738 cites W2975424845 @default.
• W4385871738 cites W3000431195 @default.
• W4385871738 cites W3011417498 @default.
• W4385871738 cites W3015163167 @default.
• W4385871738 cites W3080584333 @default.
• W4385871738 cites W3083267042 @default.
• W4385871738 cites W3092849554 @default.
• W4385871738 cites W3100071226 @default.
• W4385871738 cites W3102172621 @default.
• W4385871738 cites W3162574410 @default.
• W4385871738 cites W3194955477 @default.
• W4385871738 cites W4205494080 @default.
• W4385871738 cites W4210998119 @default.
• W4385871738 cites W4211069648 @default.
• W4385871738 cites W4296619482 @default.
• W4385871738 cites W4327640222 @default.
• W4385871738 cites W4353017596 @default.
• W4385871738 doi "https://doi.org/10.1016/s2215-0366(23)00199-2" @default.
• W4385871738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37595997" @default.
• W4385871738 hasPublicationYear "2023" @default.
• W4385871738 type Work @default.
• W4385871738 citedByCount "2" @default.
• W4385871738 countsByYear W43858717382023 @default.
• W4385871738 crossrefType "journal-article" @default.
• W4385871738 hasAuthorship W4385871738A5002251483 @default.
• W4385871738 hasAuthorship W4385871738A5011934579 @default.
• W4385871738 hasAuthorship W4385871738A5061926369 @default.
• W4385871738 hasAuthorship W4385871738A5082687875 @default.
• W4385871738 hasAuthorship W4385871738A5086167151 @default.
• W4385871738 hasBestOaLocation W43858717381 @default.
• W4385871738 hasConcept C118552586 @default.
• W4385871738 hasConcept C126322002 @default.
• W4385871738 hasConcept C139719470 @default.
• W4385871738 hasConcept C142724271 @default.
• W4385871738 hasConcept C156957248 @default.
• W4385871738 hasConcept C162324750 @default.
• W4385871738 hasConcept C168563851 @default.
• W4385871738 hasConcept C17744445 @default.
• W4385871738 hasConcept C197934379 @default.
• W4385871738 hasConcept C199539241 @default.
• W4385871738 hasConcept C204787440 @default.
• W4385871738 hasConcept C27081682 @default.
• W4385871738 hasConcept C27415008 @default.
• W4385871738 hasConcept C2776174506 @default.
• W4385871738 hasConcept C2776478404 @default.
• W4385871738 hasConcept C2776867660 @default.
• W4385871738 hasConcept C2778375690 @default.
• W4385871738 hasConcept C2779473830 @default.
• W4385871738 hasConcept C2779549880 @default.
• W4385871738 hasConcept C2780733359 @default.
• W4385871738 hasConcept C2781145037 @default.
• W4385871738 hasConcept C71924100 @default.
• W4385871738 hasConcept C95190672 @default.
• W4385871738 hasConceptScore W4385871738C118552586 @default.
• W4385871738 hasConceptScore W4385871738C126322002 @default.
• W4385871738 hasConceptScore W4385871738C139719470 @default.
• W4385871738 hasConceptScore W4385871738C142724271 @default.
• W4385871738 hasConceptScore W4385871738C156957248 @default.
• W4385871738 hasConceptScore W4385871738C162324750 @default.
• W4385871738 hasConceptScore W4385871738C168563851 @default.
• W4385871738 hasConceptScore W4385871738C17744445 @default.
• W4385871738 hasConceptScore W4385871738C197934379 @default.
• W4385871738 hasConceptScore W4385871738C199539241 @default.
• W4385871738 hasConceptScore W4385871738C204787440 @default.
• W4385871738 hasConceptScore W4385871738C27081682 @default.
• W4385871738 hasConceptScore W4385871738C27415008 @default.

• next